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ABSTRACT
EFFECTS OF ESTROGEN ON DORSAL ROOT GANGLION NEURONS
Sheila A. Scoville 
Eastern Virginia Medical School and Old Dominion University, 1997 
Director Francis J. Liuzzi, Ph. D.
Skin sensation is mediated by dorsal root ganglion (DRG) neurons. Data 
indicates that skin sensitivity in female rats is estrogen-dependent. Some DRG neurons 
have estrogen receptors (ERs) which are regulated by estrogen. In these cells, nerve 
growth factor (NGF) and estrogen receptors colocalize. Regulation o f NGF receptors 
and neuronal sensitivity to NGF may allow estrogen to regulate NGF-dependent genes. 
The goals o f the present study were to determine which DRG neurons express the ER 
gene and to analyze the effects o f long-term estrogen administration on the interrelated 
expression of tyrosine kinase A (trkA), preprotachykinin (PPT), and 68kD neurofilament 
(NF) genes and to compare warm thermal withdrawal latencies in these animals. The 
hypothesis tested by the current study was that estrogen upregulates trkA and by doing 
so, increases the sensitivity o f NGF-receptive neurons to the growth factor.
Three groups o f  ovariectomized (OVX) Sprague-Dawley rats were used: OVX 
(no replacement), IX  (taw dose) and 10X (high dose). The replacement groups 
received daily Premarin injections. Rats from each group were killed at 56 or 90 days 
and their lumbar DRGs harvested.
ER mRNA localization was done by in situ hybridization. Results showed that 
ER mRNA was o f taw abundance, but was evident in smaller neurons. Quantification 
revealed that both trkA and PPT mRNA was downregulated in both estrogen
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replacement groups at both time points when compared to the OVX group. TrkA 
mRNA was localized predominantly in small DRG neurons. PPT mRNA was restricted 
to small neurons. Estrogen treatment slowed warm thermal plantar withdrawal, but not 
significantly. Neurofilament mRNA levels were dramatically increased by 56 days of 
estrogen treatment in a dose-dependent manner in all size populations o f DRG neurons. 
Ninety days o f estrogen treatment had a similar effect.
These data indicate that estrogen regulates DRG neuronal gene expression. An 
overlapping population of DRG neurons express the ER, trkA and PPT genes. Estrogen 
may regulate the trkA and PPT genes by altering NGF sensitivity. Since the ER gene 
does not appear to be expressed by all DRG neurons, the effect o f estrogen on 
neurofilament gene expression must involve alternative mechanisms.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
To my husband, Marty, my daughter, Brooke, and my mother for their love, support 
and understanding
In memory of R. Bruce Masterton, 1931-1996.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
ACKNOWLEDGMENTS
I would especially like to thank my advisor and mentor, Dr. Frank Liuzzi who helped 
me, encouraged me and suffered with me during every phase o f my Ph. D. degree. 
His high standards for excellence in science set the benchmark for my achievement.
Special thanks go to Dr. David Scott who gave me continuous and unwaivering support 
in my efforts as both a student and a teacher.
I am grateful to my other committee members, Dr. Charles Morgan and Dr. Keith 
Carson who helped me with many special requests. They gave generously o f their time 
and expertise as members o f both my Guidance and Dissertation Committees.
I am especially appreciative for the invaluable help from Susan Button. The high quality 
in situ hybridizations in this study would not have been possible without her effort and 
expertise.
I would also like to thank Dr. Paul Kolm for his help on statistical analysis, Dr. Pauline 
Newlon for making available the Plantar Test Apparatus, and Dr. Gerald Pepe for his 
expertise on matters o f endocrinology.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
TABLE OF CONTENTS
Page
LIST OF FIGURES....................................................................................................... viii
INTRODUCTION.............................................................................................................1
BACKGROUND...........................................................................................................1
Effects o f Estrogen Throughout the Body....................................................................1
The Effects o f Aging on Somatic Sensation................................................................. 3
Behavioral Evidence of Estrogen’s Effect on Somatosensory Function ................... 5
Regulation o f DRG Neuronal Gene Expression and Function bv NGF....................... 8
Estrogen-NGF Interaction in the Regulation o f DRG Neuronal
Gene Expression and Function ...................................................................................10
Estrogen and the Estrogen Receptor...........................................................................13
GOALS OF THE CURRENT STUDY...................................................................... 20
METHODS...................................................................................................................... 21
Animals and Experimental Groups............................................................................. 21
Warm Thermal Perception Testing............................................................................ 22
Tissue Harvest and Preparation.................................................................................. 22
Probe Synthesis and in situ Hybridization.................................................................23
Quantification o f Silver Grains................................................................................... 25
Statistical Analysis .................................................................................................... 25
RESULTS....................................................................................................................... 26
Estrogen Receptor mRNA Localization in Lumbar DRG......................................... 26
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
vii
Effects o f Estrogen Treatments on High Affinity Nerve Growth Factor 
Receptor (trkA) mRNA Levels...................................................................................30
Effects o f Estrogen Treatments on Preorotachvkifiin
fPPT> mRNA Levels...................................................................................................40
Effects o f Estrogen Treatments on Warm Thermal
Withdrawal Latencies..................................................................................................48
Effects o f Estrogen Treatments on 68lcD
Neurofilament mRNA Levels......................................................................................50
DISCUSSION.................................................................................................................. 57
Estrogen Receptor Gene Expression in Lumbar DRG.........................................58
Regulation of NGF Receptor Genes bv Estrogen................................................60
Effects o f Estrogen Tretaments on PPT Gene
Expression and Nociception.................................................................................61
Warm Thermal Plantar Withdrawal Latencies......................................................63
Effects o f Long-Term Estrogen Treatment on 68kD
Neurofilament Gene Expression.......................................................................... 65
Use o f Different Forms o f Estrogen..................................................................... 67





Protocol for in situ  Hvhridiy-atinn........................................................................ 85
VITA................................................................................................................................ 86
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
LIST OF FIGURES
Figure Page
1. Depiction of the estrogen molecule, its molecular
derivation and relationship to other steroid hormones.............................................. 18
2. Schematic presentation o f the estrogen receptor
and how it is believed to a c t...................................................................................... 19
3. Bar graph comparison of uterine weights across group............................................27
4. Darkfield micrograph showing localization o f estrogen
receptor mRNA in a lumbar DRG by in situ hybridiation........................................ 29
5. Comparison of results of in situ hybridization o f DRG sections with an
anti-sense probe to trkA mRNA after 56 days o f estrogen replacement...................34
6. Histogram comparing steady state trkA mRNA levels in the DRG in OVX and
estrogen treated groups after 56 days o f treatment, (experiment 1 )......................... 35
7. Histogram comparing steady state trkA mRNA levels in DRG by in situ
hybridization after 56 days o f estrogen replacement, (experiment 2 ) ..................... 36
8. Comparison of results o f in situ hybridization o f DRG sections with
anti-sense probe to trkA mRNA after 90 days of estrogen replacement................... 38
9. Histogram comparing trkA mRNA levels in OVX and estrogen treated
groups after 90 days...................................................................................................39
10. Comparison of results of in situ hybridization o f DRG sections with antisense 
probe to preprotachyltinin (PPT) after 56 days o f estrogen replacement.................. 43
11. Histogram comparing PPT mRNA levels in OVX and
estrogen treated groups after 56 days.........................................................................44
12. Comparison of results o f an in situ hybridization with an antisense probe
to PPT after 90 days of estrogen replacement...........................................................46
13. Histogram comparing PPT mRNA levels in OVX and estrogen treated
groups after 90 days................................................................................................... 47
14. Comparison of mean withdrawal latencies on seven successive days
to a warm thermal stimulus........................................................................................ 49
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
15. Comparison o f results o f in situ hybridization of DRG sections with anti-sense 
probe to neurofilament (68 IcD) after 56 days o f estrogen replacement...............
16. Histogram comparing neurofilament mRNA levels in OVX
and estrogen treated groups after 56 days, experiment 1......................................
17. Histogram comparing neurofilament mRNA levels in OVX
and estrogen treated groups after 56 days, experiment 2......................................
18. Histogram comparing neurofilament mRNA levels in OVX
and estrogen treated groups after 90 days..............................................................




According to US Census figures, by the year 2000 around 18.5 million women 
will be peri-menopausal and another 30 million women will be in their post-menopausal 
years (U.S. Census Bureau, 1995). Considering that the median age for menopause is 
around 50 years of age, and that the life expectancy for women is now 78, one can 
expect that more than a third o f the female life span will be spent in the post-menopausal 
state (Judd, et al., 1983), that is, without cyclical naturally circulating estrogen. 
Although the role of estrogen in reproduction is comparatively well understood, its 
broader effects on non-reproductive organs are only now being discovered.
Effects of Estrogen Throughout the Body
The presence o f estrogen receptors in the ovaries, endometrium, vaginal 
epithelium, pituitary, urinary tract and skin (Utian, 1989) is well documented. 
Additionally, estrogen receptors have been shown in vascular epithelium (Buonassisi and 
Colburn, 1980) and in liver (Wrange, et al., 1980).
Other organs, such as heart and bone, are affected by estrogen, although specific 
receptors have not yet been identified in these organs (Utian, 1989). Intermediate 
mechanisms affecting serum lipids are believed to be the mode of action by which the 
heart is affected (Hazzard, 1989). Bone may also be affected by an intermediate 
mechanism. In this case, estrogen is believed to regulate interleukin-6 which supresses 
the action of osteoclasts (Jilka, et al, 1992).
The journal model used for this dissertation was the Journal of Neuroscience.
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Early studies o f the CNS have shown estrogen receptive neurons within the 
hypothalamus and limbic system (Pfaff and Keiner, 1973), regions typically associated 
with sexual behaviors. However, more recent studies suggest that estrogen receptive 
neurons are more widely distributed in the CNS, in regions not primarily involved in 
reproductive behavior. Not only are there ERs in the hypothalamus, they are also 
expressed by some neurons within the hippocampus, (Bettini, et al., 1992) cerebral 
cortex and intralaminar nuclei of the thalamus (Simeriy, et al, 1990). In a recent report, 
Toran-Allerand and her colleagues (1992) have demonstrated estrogen receptive neurons 
in the basal forebrains o f neonatal female rats and adult female mice. Nuclei containing 
these neurons include the medial septum, the vertical and the horizontal limbs of the 
diagonal band, the substantia inominata, and the nucleus basalis of Meynert. More 
interestingly, the estrogen receptors in these regions co-localize with low-affinity NGF 
receptors (p75). These investigators concluded that their data suggest that estrogen and 
NGF might act synergistically upon these neurons (Toran-Allerand, 1992).
To determine whether ER expression is a general feature of NGF receptive 
neurons, Toran-Allerand and her colleagues (Sohrabji, et al., 1994) extended their 
studies to the dorsal root ganglion (DRG) neurons o f adult female rats. They reported 
that all DRG neurons of the female rat express ER mRNA. Another laboratory, 
employing different investigative methods, (Sarajari et al, 1995, and Sarajari and 
Oblinger, 1996) has reported finding estrogen receptors only within smaller DRG 
neurons.
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The Effects o f  Aging on Somatic Sensation
Menopause, the cessation o f estrogen production by the ovaries, is characteristic 
o f normal female aging. Moreover, there is ample evidence showing an age-related 
decline in peripheral nervous system function. However, relatively little attention has 
been paid to gender differences in this decline. The ability to make light touch 
discriminations, as measured by von Frey hairs, is decreased in elderly populations on 
the palms and thumbs and on the cornea (Kenshalo, 1979). Gender was not a parameter 
in these studies. Falls and consequent fractures have a high morbidity in the 
elderly. They may, in part, result from a loss or decline in proprioception. Increased 
sway, indicative o f proprioceptive disturbance, is more severe in elderly females than in 
elderly males (Overstall, et al., 1977).
It is well established that pain and thermal thresholds increase dramatically with 
age (Tucker, et al., 1989), yet the hormonal influences on these changes have not been 
explored. As early as 1931, Critchley described in a clinical study, an age-related loss o f 
vibratory sensitivity in the feet, as well as, loss o f ankle jerk. Dyck and his colleagues 
(1993), more recently, showed a significant increase in the vibratory detection thresholds 
(VDTs) for the index finger with age. They further state that there are significant 
differences with age and a significant gender difference. Females o f all ages have lower 
VDTs than age-matched males. Whether hormonal status has any role in the decline of 
vibratory sense was beyond the scope of these studies.
Vibratory sense is mediated by large diameter, myelinated A0 axons (Martin, 
198S). The diminution in vibratory sense and reflexes in humans may, in part, be related 
to slowing of nerve conduction velocities (NCVs) with age (Wagman and Lesse, 1952).
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NCVs are determined by two axonal characteristics, axon diameter and degree of 
myelinization. Hoffman and his colleagues (1987) have provided convincing evidence 
that these interrelated features are determined by the density o f neurofilaments within 
axons. This density is determined by neurofilament gene expression and synthesis. (A 
more extensive review o f the neurofilament literature is included towards the end o f the 
introduction.) Anything that decreases neurofilament gene expression would decrease 
axon diameter and thereby decrease conduction velocity and myelin thickness.
Sharma and his colleagues (1980) identified some reduction in fiber size o f the rat 
tibial and medial plantar nerves in male rats from 2 through 24 months o f age. Since 24 
months was the extern o f this study, it is not known what further reduction in axon 
diameter might have been observed after this time. Similar age-dependent reductions in 
axon diameters have been reported for humans. Tohgi and his colleagues (1977) 
reported that the number o f nerve fibers in the sural nerve decrease with age, with a 
greater change in larger diameter axons. While one interpretation would be that there is 
a reduction of the number o f fibers, it might also represent a gradual reduction of the 
axon diameters as well as a loss o f DRG neurons. As with many other studies o f age- 
related changes in peripheral nerve, gender differences were not examined nor was 
hormonal status considered.
While both aging men and women suffer these peripheral nerve sensory deficits, 
little research has been done to specifically address the sensory changes brought on by 
menopause. Several problems come to mind. Many investigators specifically choose 
male animals for their subjects in order to remove the experimental variable o f changing 
hormonal levels due to the menstrual or estrous cycle. As Berkley points out in her 1992
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paper, in a survey o f prominent neuroscience journals, 45% o f articles in recent peer 
reviewed journals failed to report the gender o f the experimental subjects. Even less 
likely to have been studied are the differences between cycling and non-cycling females. 
The research reported in the following studies provides intriguing evidence for a link 
between menopause and declining somatosensory function in aging females.
Behavioral Evidence o f Estrogen’s Effect on Somatosensory Function
It is possible to trace a few threads o f evidence from the past. In a human 
experiment conducted 65 years ago, women were measured on their ability to make 
two-point tactile discriminations during presumed different times o f their menstrual 
cycle (Herren, 1933). Although this study documented sensitivity changes due to “the 
follicular hormone”, it attributed the mechanism of change to upper motor neuron 
inhibition mediated by the sympathetic nervous system. This study was conducted 
before estrogen had been identified as a discrete entity.
One of the first well-documented studies implicating the connection between 
estrogen and sensation was reported 35 years ago. This study dealt with hormonal 
effects on the brood patch o f the female canary (Hinde and Steele, 1964). Avian nesting 
behavior is associated with changes to a patch of skin on the breast. This region 
becomes more sensitive and defeathers in advance of egg-laying. It was found that 
exogenous administration of estrogen alone could induce an increase in sensitivity, while 
progesterone was found to be exclusively responsible for defeathering.
From 1972-1980, renewed interest in the topic produced three studies which 
demonstrated an increase in the cutaneous sensitivity of female rats which corresponded
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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to reproductive accessibility by the males. In the first o f the studies, genital skin was 
shown to be more sensitive at proestrous, the phase o f the rat reproductive cycle with 
the highest circulating estrogen (Komisurak, 1972). Increased skin sensitivity in 
response to changes in circulating estrogen proved to be a much more generalized 
phenomenon than had been suggested by the earlier investigation. Skin from other 
portions o f the rat also showed increased sensitivity during proestrus (Kow and Pfaff, 
1979). A third study added several other important pieces o f information. In that study 
by Bereiter and Barker (1980), receptive fields o f the skin o f rats were measured. At 
proestrus, electrophysiological measurements showed that the receptive fields of skin 
surface expanded an average of 22%. Furthermore, by cutting the dorsal roots, their 
procedure allowed them to rule out the possibility o f CNS involvement, thus assuring 
that the phenomenon is a peripheral one.
Since the time o f those studies, a great deal has been learned about DRG 
neurons, their gene expression and function. This new knowledge may provide the basis 
for an understanding of estrogen’s role in modulating cutaneous sensation. 
Morphologists have traditionally described the DRG neurons as either “small dark” or 
“large light” (Lawson, 1979) and describe their axons by diameter and degree of 
myelination (Martin, 1985). More recent schemes describe DRG neurons in terms of 
their transmitters or neuropeptide content. For example, subpopulations of DRG 
neurons have been identified immuno-histochemically by their calcitonin gene-related 
peptide (CGRP) or Substance P content (Verge et al 1989b). Very recently, Wright and 
Snider (1995) categorized DRG neurons by the type o f neurotrophin receptors they 
expressed. Still others have subdivided and characterized these sensory neurons by their
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
7
sensory receptor type, such as the Pacinian corpuscle or the free nerve ending. 
Physiologists, based on conduction velocities and patterns o f electrical activity, have 
categorized these cells into 22 types (Snider, personal communication).
From a behavioral point o f view, somatic sensations are described as pain, 
thermal sensations o f heat and cold, light touch, discriminative touch, vibration and 
proprioception. The field o f psychophysics seeks to document sensations and changes 
in these sensations through batteries o f sensory testing. The von Frey test, for example, 
documents tactile sensitivity by applying a series o f hairs in graded diameters.
All of these methods o f characterizing DRG sensory neurons have begun to 
provide a broad understanding o f primary sensory neurons and the sensations subserved 
by them. A new challenge, however, is to begin to understand the role o f estrogen, and 
potentially other hormones, in the regulation of DRG neuronal gene expression, function 
and, ultimately, cutaneous sensation.
Regulation o f DRG Neuronal Gene Expression and Function bv NGF
Since the characterization o f NGF by Levi-Montalcini (reviewed by Bendiner, 
1992), scientists have sought to understand the role of the neurotrophic molecule and its 
relatives in neuronal development, maintenance and function. To date, NGF is known to 
be important developmentally for the survival o f neural crest-derived neurons. 
Furthermore, it is known to promote neurite outgrowth in tissue culture (Grafstein and 
McQuarrie, 1978) and support the survival of axotomized sensory neurons in the adult 
(Rich, et al., 1987). NGF regulates the production o f neurofilaments in NGF-dependent 
DRG neurons (Verge, et al., 1990) as well as the neuropeptides, CGRP and substance P
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in those cells (Lindsay and Harmar, 1989). Additionally, the receptors for NGF, high 
affinity (trkA) and low affinity (p75) have been characterized (reviewed by Chao, 1992).
About 40% o f DRG neurons bind NGF and express the high affinity NGF (trkA) 
receptor gene (Verge, et al., 1989a). These neurons also express the low affinity NGF 
receptor (p75). However, other neurons in the DRG express the p75 gene only and fail 
to bind NGF (Verge, et al., 1989a). These other neurons express trkB and trkC (Wright 
and Snider, 1995) and bind other members o f the neurotrophin family, BDNF and NT3 
(reviewed by Chao, 1992).
A study using transections o f the sciatic nerve and infusions of exogenous NGF 
has shown that NGF regulates p75 and trkA in those neurons that bind NGF (Verge, et 
al, 1992). Cutting the sciatic nerve removes target-derived NGF and causes a dramatic 
decline in DRG neuronal high affinity NGF receptor binding as well as in trkA and p75 
mRNA -Intrathecal infusion of exogenous NGF restores receptor binding and returns 
the receptor mRNA levels toward normal.
Not only does NGF regulate its receptors, it has been shown to regulate other 
genes in those neurons that bind NGF with high affinity. There is, for example, a well 
established relationship between NGF and neuropeptide gene expression in DRG 
neurons. An in vitro study by Lindsay and Harmar (1989) showed that NGF regulates 
calcitonin gene-related peptide (CGRP) and preprotachykinin (PPT) gene expression in 
adult DRG neurons. The PPT gene encodes the precursor to substance P. This 
undecapeptide is a putative nociceptive neurotransmitter (Duggan, et al., 1987; 1988) 
and its depletion results in thermal analgesia (Yaksh, et al., 1979). A later, in vivo study
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showed that the decline in substance P following sciatic nerve transection is reversed by 
infusion o f NGF to the proximal cut end o f the nerve (Wong and Oblinger, 1987).
In the same study, Wong and Oblinger (1987) reported that exogenous NGF did 
not reverse the decline in lumbar DRG neurofilament gene expression that follows 
transection o f the sciatic nerve. Contrary to this report, however, is substantive indirect, 
(Gold, et al., 1991) as well as, direct evidence that NGF regulates the synthesis of 
intermediate filaments in, at least, the NGF binding subpopulation o f DRG neurons 
(Verge etal., 1990).
Neurofilaments are a major structural component of neurons and are particularly 
abundant in large diameter axons (Friede and Samorajski, 1970). These intermediate 
filaments are comprised o f three protein subunits, which are encoded by separate genes 
(Julien et al, 1986). Neuronal size and axon diameter are proportional to the number of 
neurofilaments (Hoffinan, et al., 1988). Paul Hoffinan and his colleagues, based on 
substantive experimental evidence, have argued that neurofilaments are essential to the 
maintenance of axon diameter and thereby, govern conduction velocity (Hoffinan, et al, 
1984, 1985, 1987). Moreover, since myelin thickness is correlated with axon diameter, 
it follows logically that axonal neurofilament content determines myelin thickness.
Axotomy causes neurofilament synthesis to decline (Oblinger and Lasek, 1988). 
Reconnection of axons with their targets restores neurofilament gene expression and 
synthesis (Hoffinan, 1987) suggesting that target-derived growth factors, such as NGF, 
regulate neurofilament gene expression. In cultured rat pheochromocytoma cells, NGF 
upregulates all three subunits (Lindenbaum, 1988). Moreover, NGF deprivation in vivo 
by antibody infusion causes sensory axonal atrophy (Matheson, 1989). This atrophy has
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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been tied to decreased neurofilament synthesis (Gold, et al., 1991). Verge and 
colleagues (1990) found that after axotomy, neurofilament synthesis was significantly 
decreased in large DRG neurons. Administration o f NGF to the DRG somata restored 
neurofilament production in only that small proportion of these large neurons that bind 
NGF with high affinity. They concluded that NGF regulates neurofilament gene 
expression in NGF-dependent DRG neurons through some intermediate mechanism. In 
the 60% of the DRG neurons that are not NGF-dependent, neurofilament synthesis must 
be regulated by other target-derived factors, perhaps, the other neurotrophins.
Estrogen-NGF Interaction in the Regulation of DRG Neuronal Gene Expression and 
Function
A recent study by Sohrabji and her colleagues (1994) shows that estrogen 
receptors co-localizes with neurotrophin receptors in DRGs. Moreover, circulating 
estrogen levels regulate DRG neuronal estrogen receptor gene expression. For example, 
at proestrus, when estrogen levels are highest, estrogen receptor mRNA is at its lowest. 
In ovariectomized (OVX; estrogen deficient) rats, estrogen receptor mRNA levels are 
highest. Additionally, estrogen replacement to proestrus levels restores estrogen 
receptor mRNA levels to their lowest levels. Thus, as in other systems, estrogen 
regulates its receptor.
More importantly, there is evidence that estrogen regulates DRG trkA and p75 
gene expression (Sohrabji, et al., 1994). During proestrus, with the highest estrogen 
levels, trkA is up-regulated. Similarly, p75 is up-regulated during proestrus. Sohrabji 
and her colleagues (1994) found that OVX down-regulates both of these NGF receptor
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genes. Unfortunately, it is not entirely clear how to interpret the effects o f replacement 
estrogen. They found that estrogen replacement transiently decreased p75 mRNA levels 
at four hours post-replacement, while at 52 hours there was no difference in p75 mRNA 
levels in DRGs o f OVX rats and OVX rats receiving estrogen. These data suggest that 
estrogen, through its action on the NGF receptors, may alter foe sensitivity o f DRG 
neurons to NGF. In this way, estrogen might act in synergy with NGF to regulate 
genes necessary for primary sensory neuronal function.
Recent evidence supports foe idea of such a synergistic interaction between 
estrogen and NGF in foe regulation o f CGRP and substance P. Sarajari and her 
colleagues (1995), using immunohistochemistry, reported that there were high levels o f 
ER immunoreactivity in only foe small DRG neurons, but not the larger cells. This 
finding is somewhat surprising in light o f Sohrabji and her colleagues (1994) data 
showing ER mRNA in all large and small DRG neurons. The difference in these findings 
might be explained by foe difference in experimental approaches used by the two groups. 
The in situ hybridization used by Sohrabji and colleagues (1994) may be a more sensitive 
method than foe immunohistochemical method used by Sarajari and colleagues (1995). 
This controversial issue, i.e. which DRG neurons express foe ER gene is examined in the 
current research.
Regardless, Sarajari and co-workers (1995) were able to co-localize CGRP, 
substance P and ER in the smaller DRG neurons. They showed further that CGRP 
immunoreactivity was increased in OVX rats receiving estrogen compared to those not 
receiving estrogen replacement. Furthermore, they show that this pattern is present at 
very early post-natal stages (Sarajari, et al., 1996). Contrary, however, to what might
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be expected based on Lindsay’s and Namur's (1989) report showing up-regulation of 
both CGRP and PPT genes by NGF in cultured adult DRG neurons, Sarajari and her 
colleagues (1995) reported a decrease in substance P immunoreactivity in estrogen- 
treated OVX rats. If  estrogen does indeed up-regulate the DRG neuronal NGF 
receptors, as reported by Sohrabji and her colleagues (1994), and thereby enhances the 
sensitivity of those neurons to NGF, it becomes difficult to understand the differential 
regulation of the two neuropeptides by estrogen reported by Sarajari and her colleagues 
(1995). The answer may depend on an understanding of the time course o f the 
regulatory events.
By contrast, if  as Sohrabji and her colleagues (1994) have shown, trkA and p75 
are up-regulated by estrogen, one might also expect substance P to be up-regulated. An 
up-regulation o f substance P would, in turn, be expected to decrease pain and 
temperature thresholds. Evidence supporting this expectation was recently provided in a 
study by Frye and her colleagues (1992). They used the tailflick latency to a focused 
light beam as a measurement o f thermally induced nociception to examine the effects o f 
estrus cycle on pain and temperature. They found significant differences in sensitivity at 
different phases o f the cycle. During proestrus (highest circulating levels of estrogen) 
they found the lowest tailflick latencies, while during metestrus (lowest circulating 
estrogen levels), the tailflick latencies were at their highest. In the current study the 
interrelationships among chronic estrogen administration, trkA gene expression, PPT 
gene expression and warm thermal withdrawal latencies are determined.
Not only does NGF regulate substance P gene expression, it also regulates AS 
and C fiber afferent collateralization in the skin (Diamond, et al., 1992). Thus, elevated
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
13
circulating estrogen levels should, through their effects on DRG NGF receptor genes, 
cause expansion o f the receptive fields for these fibers. This may be the case. Moreover, 
neurofilament gene expression and synthesis may be essential for maintenance o f this 
collateralization.
Nearly 25 years ago, it was suggested that hormones acted peripherally to 
increase skin sensitivity (Komisaruk, et al., 1972: Kow and Pfaff 1973). Three groups of 
investigators Bereiter and Barker (1980), Komisaruk and colleagues (1972), and Kow 
and Pfaff (1973) have all found that estrogen replacement increased cutaneous receptive 
fields in OVX rats. The mean receptive field size of the pudendal nerve in treated rats 
was 22% larger than that in untreated OVX rats (Kow and Pfaff, 1973). Bereiter and 
Barker, (1975) expanded our understanding of this phenomenon by demonstrating 
receptive field enlargement in skin o f the facial region in OVX rats which were given 
replacement estrogen, in addition to the genital skin areas which had been studied by 
these earlier investigators.
Estrogen and the Estrogen Receptor
Because the work in this dissertation is focused on the effects o f estrogen on one 
of its recently discovered target tissues, the DRG, not on the intricacies o f genetic 
activation, little attention will be focused at the molecular level, as is true of the issues 
concerning gene activation. In this body o f work, molecular biology is used as a tool for 
achieving the research aims o f this study. Nonetheless, a basic description and an 
understanding o f the current thinking on these mechanisms is necessary in order to
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interpret some o f the apparently disparate results o f previous research and is included at 
this time.
There are three categories o f steroid hormones: the adrenal steroids, vitamin D3 
and the sex steroids. Estrogen as well as progesterone and testosterone comprise the sex 
hormones. These and other steroid hormones are derived from cholesterol. Cholesterol 
is one of the most basic and one o f the phylogenedcally oldest molecules o f life since it 
is an important component o f the cell membrane (Evans, 1988). The ovary is 
responsible for the production o f circulating estrogen in the adult female. The other 
major sex hormones produced by the ovaries are progesterone and the androgens which 
are comprised mostly o f testosterone and androstenedione. The circulating levels o f 
these hormones vary greatly depending on the stage o f the menstrual cycle o f the adult 
human female or the corresponding estrous cycle o f the rat. The interactions o f these 
sex steroids are extremely important but are well beyond the scope o f the body o f 
information presented in this paper.
The two major components o f estrogen are estradiol and estrone. Their 
molecular derivation, as well as that o f testosterone, is depicted in Figure 1 (modified 
from Stryer, 1987). These two estrogens can be converted into 40 known metabolic 
products, although most o f these are intermediate breakdown products destined for 
excretion (Erickson and Scheiber, 1995). A few o f these metabolites are biologically 
active. If the estradiol or estrone molecule becomes hydroxilated at the 2 or 4 position, 
they become known as catechol estrogens. Although the significance o f these molecules 
is not understood, one study finds relatively high concentrations of these estrogen forms 
in the pituitary and hypothalamus (Paul and Axelrod, 1977). Also, the molecular
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configuration (conformation) o f estradiol (17-beta estradiol vs. 17-alpha estradiol) may 
prove to be important for biological activity.
How do hormones have such diverse effects within the body? In order for any 
circulating hormone to have an effect upon a particular target organ it binds to receptors 
of the cells o f the various tissues. Until a few years ago, a discussion o f the ER would 
have been quite simple. A newly emerging picture, however, is much more complicated. 
The ER, along with other steroid hormone receptors, glucocorticoid and 
mineralocorticoid receptors and the sterol vitamin D receptor comprise a “superfamily” 
of receptors. And although the ligands are dissimilar, the receptors for retinoic acid 
(Vitamin A) also show considerable homology to the hormone receptors. The first 
formulation o f the nature o f the ER occurred in the early 1970’s with the use of 
radioactive ligands (Evans, 1988). It had been determined earlier that the action of 
estrogen was not due to local metabolism within the tissue, since when estrogen was 
administered at physiological doses, it was retained within the target tissue (Jensen, 
1960). This original observation led to the search for hormone receptors in general, and 
specifically estrogen receptors.
A widely accepted view arose that ERs resided in the cytosol and, when bound 
by hormone migrated to the nucleus where the complex bound to the DNA strand. The 
now, more widely accepted view was presented in back-to-back Nature papers by King 
and Greene (1984) and Gorski and colleagues (Weishons et al., 1984). The first paper 
localized occupied and unoccupied ERs within the nuclei o f cells. This evidence 
suggested that since unoccupied receptors can be found in the nucleus, cytosolic 
receptor binding was not a  prerequisite for estrogen’s action. The second paper, partially
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reinterpreting their earlier results, presented evidence that the presence o f estrogen 
receptors in the cytosol was largely or wholly artefactual due to methodology. In 
summary, although the idea o f translocation o f estrogen bound to its receptor from the 
cytosol to the nucleus has a few proponents, that theory has been discarded. Current 
techniques are able to demonstrate few or no estrogen receptors in the cytosol. Instead, 
they are believed to be confined to the nucleus. Some evidence exists that the site of 
new receptor synthesis is on the outer surface o f the nuclear membrane and that the 
newly formed receptor moves to the interior o f the nucleus at, or shortly after the time of 
synthesis (Tumohimaa, et al., 1988). Another variation of this idea is that the newly 
bound receptors, which are molecular monomers, bind with another and pass to the inner 
side of the nuclear envelope as a dimer (Carson-Jurica et al., 1990).
Another evolving theory, which is gaining support, has to do with the nature of 
the unbound receptor. Steroid receptors are now referred to as being inactive when not 
bound by specific ligands (Carson-Jurica et al, 1990). When hormones enter the cell, the 
receptors become activated or transformed. The inactive state o f the ER is now believed 
to be dependent upon the receptor’s association with one or more intracellular proteins. 
Currently, heat shock proteins, especially HSP 90, are believed to be the particular 
proteins which competitively bind to the DNA binding location of the receptor complex 
(Ing and O’Malley, 199S). Additional evidence indicates that this binding apparently 
works by more than simple competition for binding sites since experimental removal of 
the HSPs from unbound receptors does not activate them (Meshinchi, 1988). A 
conceptualization of theorized interactions o f the estrogen receptor with its ligand is 
presented in Figure 2 (modified from Carson-Jurica, 1990).
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Regardless o f whether or not a different receptor type is present in the cytosol or 
nucleus, an entire new category of non-traditional steroid receptor is beginning to be 
elucidated. Evidence for a membrane receptor comes predominantly from physiological 
experiments (Mermdstein, 1996). Although previous investigations have been 
accumulating evidence that identified neural areas with no known cytosolic or nuclear 
estrogen receptors, few have postulated the heretical mechanism of a hormone 
membrane receptor to explain results. Mermelstein and coworkers (1996) have 
presented evidence that estrogen may also act on a membrane calcium channel in CNS 
neurons.
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Figure 1. Depiction o f the estrogen molecule, its molecular derivation and relationship 
to other steroid hormones. Note that both major components of estrogen, estrone and 
estradiol are shown.














Figure 2. Schematic presentation of the estrogen receptor and how it is believed to act.
The estrogen molecule (E) passes through the plasma membrane and binds to the
inactive estrogen receptor (ER) which is positioned in the outer nuclear membrane. In 
its inactivated state the ER is bound by a heat shock protein (HSP). When the receptor 
is bound by the estrogen molecule, the heat shock protein drops off and the bound 
estrogen receptor binds to another ER complex (RC) and passes through the nuclear 
envelope as a dimer where irattaches to a site on the gene known as the estrogen
response element (ERE). At this point the gene is activated and transcription
commences. The resulting mRNA moves to the cytosol where translation occurs.
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GOALS OF THE CURRENT STUDY
The current research had two main goals. The first goal was to settle the 
controversial issue o f whether all or only a subpopulation o f DRG neurons express the 
estrogen receptor gene. To this end, in situ hybridization with an anti-sense RNA probe 
to the rat ER was used to localize ER mRNA in sections o f lumbar DRGs.
The second, main objective o f the current study was to analyze the 
interrelationships among long-term estrogen administration, trkA gene expression, PPT 
gene expression and warm thermal withdrawal latencies. Specifically, the hypothesis 
tested by the current study was that estrogen upregulates trkA and by doing so, increases 
the sensitivity o f NGF-receptive neurons to the growth factor. Furthermore, if long term 
estrogen treatment increases the sensitivity of DRG neurons to NGF, the known NGF- 
dependent genes, PPT and 68kD neurofilament should, consequently, be upregulated.
To test this hypothesis, the effects of long-term estrogen treatment on high 
affinity NGF receptor (trkA) mRNA levels was examined using quantitative in situ 
hybridization with an anti-sense RNA probe to trkA  Additionally, similar methods were 
used to examine the effects o f long-term estrogen on PPT and 68kD neurofilament 
mRNA levels. Finally, a behavioral correlate of changes in PPT gene expression was 
examined. The Hargreaves’ method to measure withdrawal latencies to warm thermal 
stimuli in response to long-term estrogen treatment was done with a plantar test 
apparatus.
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Animals and Experimental Groups
Forty-three adult female OVX Sprague-Dawley (Harlan Sprague Dawley) were 
used for this study. Animals were purchased, maintained and treated according to the 
Eastern Virginia Medical School Animal Care and Use Committee standards and the 
NIH Guide fo r  d»e Care and Use o f Laboratory Animals (approved protocols are on file 
in the Office o f Research). The rats, weighing 200-300 grams at the commencement of 
the study, were randomly assigned to three groups two weeks post-ovariectomy.
Rats in the first group were ovariectomized with no estrogen replacement. This 
group is referred to as the OVX group. Bilateral ovariectomies were done at the Harlan 
facilities. Those in the second group were ovariectomized and received daily 
subcutaneous estrogen (Premarin, Wyeth-Ayerst) injections at a dose (0.022mg/kg) 
calculated to result in physiological serum estrogen titers (Washburn, et al., 1993) This 
group is referred to as IX, the low dose group. The rats in the third group were 
ovariectomized and given replacement estrogen subcutaneously at 10 times the daily 
dose (0.22mg/kg) given to Group 2. This group is referred to as 10X, the high dose 
group.
Normal, age-matched female rats provided baseline uterine weights for 
assessment of the effects of estrogen treatments (see Figure 3 in Results). During the 
length of the study, all animals were housed in community cages with 3-4 animals per 
cage at the EVMS animal care facility. All subjects were given unlimited standard rat 
chow and water. The day-night cycle was maintained at 12 hours each of light and dark. 
Animals in the three groups were killed after either 56 or 90 days o f estrogen treatment.
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Warm Thermal Perception Testing
The Hargreaves' method for testing warm thermal perception used the Plantar 
Test Apparatus (Ugo Basile Biological Research Apparatus, Co.)- This apparatus used a 
light (heat) source capable o f emitting a focused light beam. The source was positioned 
under the hind paw o f the rat subject which was confined in an elevated plexiglas 
compartment. The beam was manually started and when the beam was interrupted by 
foot withdrawal the trial was automatically terminated. The apparatus' timing device 
measured the trials in tenths o f seconds. A detailed explanation o f this apparatus is 
reported by Hargreaves (1988). Subjects assigned the 90 day survival time were tested 
daily for seven days beginning at day 80. The order o f testing was chosen blindly and 
subjects were identified after their trial.
Tissue Harvest and Preparation
After 56 days, three rats from each o f the three groups were euthanized. After 
90 days the remaining 34 rats were killed. After receiving a lethal overdose o f a mixture 
of ketamine and xylazine, (160 mg/Kg ketamine, 16 mg/Kg xylazine) the animals were 
perfused through the ascending aorta with physiological saline followed by 10% 
phosphate-buffered formalin. The dorsal root ganglia were removed bilaterally from L4- 
L6 and collected into fresh 10% buffered formalin. Uteri from the 90-day animals and 
age-matched normal females were harvested and weighed. The DRGs were embedded 
in low melting point paraffin with special precautions taken to prevent RNAse 
contamination. Following embedding, 5 pm sections were cut on an American Optical 
paraffin microtome and placed on Fisherbrand Superfrost slides.
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Probe Synthesis and in situ Hybridization
The ER cDNA used for antisense and sense RNA probe synthesis was a 560 base pair 
fragment from the N-terminus incuding a portion o f the binding pocket unique to the 
estrogen receptor It was a gift from Dr. Paul Shugrue (Wyeth-Ayerst) and was used 
with permission o f the originator, Dr. M. Muramatsu. The sequence was described by 
Koike and colleagues (1987).
The trkA cDNA was obtained from Genentech. It was a 545 base pair fragment 
taken from the extracellular domain. The PPT cDNA was a 560 base pair fragment 
identified as beta PPT. The DNA fragment used was from a gene region which is 
uniquely a precursor to substance P (Krause, et al, 1987). It was obtained from Dr. 
Susan Leeman at Harvard University. The neurofilament cDNA was a 1.2kB fragment 
cloned from the gene specific for the 68 kD neurofilament subunit (Lewis and Cowan, 
1985). It was a gift from Dr. Oswald Steward, University o f Virginia, and used with the 
permission o f its originator, Dr. Nick Cowan at New York University.
Detailed technical protocols for probe synthesis and in situ hybridization are 
included in the Appendix. Briefly, sense and antisense RNA probes were radiolabelled 
with p33 UTP using a Promega probe synthesis kit (Promega Riboprobe In Vitro 
Transcription System). Unincorporated isotope was removed by filtering through a TE 
Midi Select Column (Sigma). After the addition o f tRNA, the probes were shortened 
to approximately 150 base pairs by alkaline hydrolysis. Probes were precipitated 
overnight, then pelleted, resuspended and counted with a scintillation counter to 
determine radionucleotide incorporation. Protocols for radioisotope usage have been
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approved by the EVMS Radiation Safety Committee and are on file in the Office of 
Research.
Tissues were examined by in situ hybridization techniques to localize mRNA for 
rat estrogen receptor. Quantitative m situ  hybridization was used to localize and 
quantify trkA, the high affinity NGF receptor, preprotachyldnin (PPT; the substance P 
precursor) and 68kD neurofilament mRNAs.
Sections were given a pretreatment, hybridized, and post-hybridized. In the 
pretreatment, the sections were deparaffinized with xylene and rehydrated in graded 
alcohols. The sections were then permeablized in a 0.2% HC1 bath and incubated in 
proteinase K at 37°C. The sections were fixed in formaldehyde then acetylated with 
0.1M triethanolamine with 0.25% acetic anhydride. After rinsing, sections were 
dehydrated in graded alcohols, delipidated with chloroform and dried under vacuum.
During hybridization, tissue sections were treated with sense and antisense 
probes which were added to the hybridization solution consisting o f 50% formamide, 
,3MNaCl, 20mM Tris-HCl, EDTA, Denhardt’s solution, salmon sperm DNA, Torules 
Yeast RNA, DEPC treated water and dextran sulfate pipetted onto the slides and 
incubated overnight in a 60°C humid chamber. In the post-hybridization portion of the 
procedure, slides were washed, dehydrated and Rnase treated. Slides were again washed 
and dehydrated, then exposed to Hyperfilm-beta (Amersham, Arlington Heights, 111) for 
2-4 days. Slides were coated with Kodak NTB2 nuclear emulsion diluted at a 1:1 ratio 
with distilled water, and after 6-21 days (for TrkA, neurofilament and ppt) were 
developed with a Kodak Dektol and Kodak fixer. Slides were stained for microscopic 
analysis with a hematoxylin and eosin preparation or cresyl violet.
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Quantification of Silver Grains
The in situ hybridations were quantified by an Image I (Universal Imaging 
Corporation) image analysis system according to the method o f McNamara (1993). For 
this study, slides were blindly coded and non-overlapping fields o f neurons were 
counted. Areas with large numbers of axons were not included. At least 10, and up to 
40 observations were made for each slide. A minimum o f two slides was used for each 
subject which served as an internal control for consistency. That is, if specific 
hybridization was detected on one slide but not on another, the case was discarded. 
Background counts were made from glass adjacent to the tissue sections and subtracted 
from the field counts. Sense slides were examined for signal.
Statistical Analysis
A mixed model ANOVA statistical analysis was performed on numerical data 
collected during grain counting from the in situ  hybridization slides. Analysis o f the foot 
withdrawal data was performed with a seven-by-three repeated measures ANOVA. 
The choice o f the tests were recommended and the analyses performed by Paul Kolm, 
Ph.D., the biostatistician at EVMS.
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RESULTS
At the time o f euthanization, the absence o f ovaries was confirmed in all 
experimental animals. Figure 3 is a histogram comparing mean uterine weights o f the 
three experimental groups with the mean uterine weight o f normal cycling females. The 
distinct differences between the mean weights o f OVX versus estrogen-replaced or 
normal uteri was considered ample proof o f the removal of endogenous estrogen by 
ovariectomy and restoration of circulating estrogen in the treated animals. Upon 
reviewing these data, Gerald Pepe, Ph.D. (personal communication), an expert on 
estrogen and estrogen treatment, suggested that no further assay was needed as 
verification o f estrogen status.
Estrogen Receptor mRNA Localization in Lumbar DRG
Micrographs showing the localization o f ER mRNA within the DRG o f an OVX 
animal from Group 1 by in situ hybridization with the ER RNA probe are presented in 
Figure 4. The darkfield micrograph clearly reveals detectable ER mRNA in a 
subpopulation o f predominantly smaller DRG neurons. The higher magnification 
brightfield micrograph shows mRNA localization in smaller neurons (arrow). Larger 
neurons were generally unlabelled by hybridization with the antisense RNA probe to the 
rat ER. The sense probe verified the specificity o f the antisense probe and revealed no 
hybridization to the DRG sections (data not shown).
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Figure 3. Bar graph comparison o f uterine weights across groups. Low weights confirm 
a lack of circulating estrogen in the OVX group. Note that replacement groups means and 
the sham operated group mean were nearly three to five times that o f the OVX group.
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Figure 4. Darkfield micrograph showing localization of estrogen receptor mRNA in a 
lumbar DRG by in situ  hybridiation (A). The same section in brightfield illumination and 
at a higher magnification is shown in (B). Bar in darkfield is 100pm. Bar in brightfield 
is 50pm. The arrows identify the same cluster o f neurons in both micrographs.
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Effects o f Estrogen Treatments on High Affinity Nerve Growth Factor Receptor (trkA) 
mRNA Levels
Results o f the in situ hybridization studies using the RNA probe for the high 
affinty nerve growth factor, trkA, are presented in Figures 5-9. Figure 5 compares the 
hybridization o f the probe to DRG sections from the three groups after 56 days o f daily 
estrogen treatment in the IX and 10X groups. Figures 5A and 5B are darkfield and 
brightfield micrographs o f a DRG section from an OVX animal. The trkA mRNA was 
observed mostly, but not exclusively, in small diameter DRG neurons. Micrographs C 
and D (IX  treatment) and E and F (10X treatment) reduces the hybridization o f the trkA 
probe to the tissue indicating reductions in the amounts o f trkA mRNA in these tissues.
Two separate in situ hybridization experiments were done. Quantitative 
comparisons o f results were performed on tissues hybridized at the same time under 
identical conditions. Results of the quantification and statistical analyses o f trkA 
experiment 1 are shown in Figure 6. After 56 days o f estrogen replacement the mean 
trkA steady state level o f the OVX group was 2472.47 grains per region area (gr/rA) 
with a standard deviation of 1746.57 gr/rA. The mean trkA steady state level for the 
IX group was 1629.9 gr/rA with a standard deviation o f 826.9 gr/rA while the mean 
level for the 10X group was 2084.42 gr/rA with a standard deviation of 1318.22 gr/rA. 
Statistical analyses revealed that the mean trkA for the OVX was significantly greater 
than that o f the IX group (p -  .0115). The statistical difference difference between the 
IX group and the 10X group was not significant. The treatment group effect was 
significant (p = .0159).
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Figure 7 is a histogram showing the results o f the quantitative analyses of the 
hybridization o f the trlcA probe to the DRGs in in situ  hybridization experiment 2. This 
experiment was performed in a manner identical to experiment 1, but on DRG sections 
from different animals from the three groups. The mean steady state mRNA level for the 
OVX group was 5320.75 gr/rA with a standard deviation o f 3928.98 gr/rA  The mean 
steady state trkA mRNA level for the IX group was 3654.26 gr/rA with a standard 
deviation o f 1844.74 gr/rA  while that for the 10X group was 3846.8 gr/rA with a 
standard deviation o f 2364.17 gr/rA  Statistical analyses revealed that the mean steady 
state trkA mRNA level o f the OVX group was significantly greater than the mean o f the 
IX group (p=.0273). The differences between the OVX and the 10X group was nearly 
significant (p= .0583).
Figure 8 consists o f micrographs showing the results o f hybridization of DRG 
sections from the three groups with the trkA RNA probe after 90 days of estrogen 
treatment. The qualitative results o f the longer-term treatment are similar to those o f the 
56-day treatment, i.e. estrogen treatments reduce the amounts o f trkA mRNA in 
predominantly smaller DRG neurons.
The results of quantification o f silver grains indicating trkA mRNA in the DRG 
sections from the three groups after 90-day of estrogen treatments are presented in 
Figure 9. The mean steady state trkA mRNA level for the OVX group was 661.56 
gr/rA with a standard deviation o f 429.41 gr/rA  That for the IX  group was 424.86 
gr/rA with a standard deviation o f 272.04 gr/rA  while the mean steady state trkA 
mRNA level for the 10X group was 424.86 with a standard deviation of 201.39. In the 
case of 90 days of estrogen treatments, statistical analyses showed that the mean steady
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state trkA mRNA level for the OVX group was significantly greater than those from 
either estrogen replacement group (p< .0001).
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Figure 5. Comparison of results o f in situ hybridization o f DRG sections with an anti­
sense probe to trkA mRNA after 56 days o f estrogen replacement. Micrographs A, C 
and E  are shown in darkfield. Micrographs B, D  and E  are shown in brightfield, at a 
higher magnification. Sections A and B  are from an OVX animal. Sections C and D are 
from a IX animal. Sections E  and F  are from a 10X animal. All darkfield micrographs 
are at the same magnification (Bar=100|im). Brightfield micrographs are at the same 
magnification (Bar=50pm).
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Figure 6. Histogram comparing steady state trkA mRNA levels in the DRG in OVX and 
estrogen treated groups after 56 days o f treatment, (experiment 1)
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Figure 7. Histogram comparing steady state trkA mRNA levels in DRG by in situ 
hybridization after 56 days o f estrogen replacement, (experiment 2) Subjects used for this 
experiment are from the same pool of subjects within each group, but are not identical to 
those used in experiment 1.
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Figure 8. Comparison o f results o f in situ hybridization o f DRG sections with anti­
sense probe to trkA mRNA after 90 days of estrogen replacement. Micrographs A, C 
and E  are shown in darkfield. Corresponding sections are shown at a higher 
magnification in brightfield in B, D  and F. Sections shown in A and B  are from an OVX 
animal. Sections shown in C and D  are from a IX animal. Sections shown in E  and F  
are from a 10X animal. Darkfield micrographs are at the same magnification (Bar=100 
fim). Brightfield micrographs are at the same magnification (Bar=50 nm). Arrows 
indicate the same neurons in darkfield and brightfield.
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Figure 9. Histogram comparing trkA mRNA levels in OVX and estrogen treated groups 
after 90 days. Means in the replacement groups are significantly lower from that of the 
OVX group (p <0.0001 for both comparisons).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
40
Effects of Estrogen Treatments on Preprotachvkinin (PPT) mRNA Levels
Results o f the in situ hybridization experiments using an RNA probe for the PPT 
gene are presented in figures 10-13. Figure 10 is a comparison o f micrographs o f DRG 
sections hybridized with the PPT probe from the three treatment groups after 56 days of 
treatments. The PPT mRNA, as would be expected from previous studies showing 
localization o f substance P peptide, was found mainly in smaller DRG neurons. The 
estrogen treatments appeared to reduce the amount o f mRNA in DRG sections from the 
treated groups.
A histogram comparing mean steady state PPT mRNA levels across the three 
groups after 56 days of estrogen treatments is shown in Figure 11. The mean steady 
state level PPT mRNA level for the OVX group (1521 gr/rA) was greater than either the 
mean steady state PPT mRNA levels for the IX  treatment group (901 gr/rA) or the 10X 
treatment group (836 gr/rA).
After 90 days of treatments, PPT steady state mRNA levels were decreased by 
estrogen replacement therapies, as was observed after 56 days o f estrogen treatments. 
These data are shown in the comparison o f micrographs in Figure 12. As was seen after 
56 days of treatment, there is an apparent decrease in the numbers o f silver grains 
indicative of PPT mRNA localization over the DRG sections from the estrogen treated 
animals.
A histogram depicting quantification o f these differences is shown in Figure 13. 
Here, the mean steady state PPT mRNA level for the OVX group was 661.56 gr/rA with 
a standard deviation o f 429.41 gr/rA. That for the IX group was 421.33 gr/rA with a 
standard deviation o f272.04 gr/rA, while the mean steady state PPT mRNA level for the
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10X group after 90 days o f estrogen treatment was 424.86 gr/rA with a standard 
deviation o f 201.39 gr/rA. The mean steady state PPT mRNA levels for both estrogen 
replacement groups were significantly lower than the that for the OVX group (p <
.0001).
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Figure 10. Comparison o f results o f in situ hybridization o f DRG sections with anti­
sense probe to preprotachykinin (PPT) after 56 days o f estrogen replacement. 
Micrographs A, C and E  are shown in darkfield, and micrographs B, D, and F  are shown 
in brightfield, at a higher magnification. Sections shown in A and B  are o f an OVX 
animal. Sections shown in C and D  are from a IX  animal. Sections shown in E  and F  
are from a 10X animal. Micrographs A, C and E  are at the same magnification 
(Bar=100 pm). Micrographs B, D  and F  are at the same magnification (Bar=50 pm).
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Figure 11. Histogram comparing o f PPT mRNA levels in OVX and estrogen treated 
groups after 56 days.
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Figure 12. Comparison o f results o f an in situ  hybridization with an antisense probe to 
PPT after 90 days o f estrogen replacement. Sections A, C and E  are darkfield 
micrographs. Sections B, D  and F  are higher magnification brightfield micrographs. 
Sections A and B  are from an OVX animal. Sections B  and C are from an animal 
receiving IX replacement estrogen. Sections D  and F  are from an animal receiving 10X 
replacement estrogen. Micrographs A, C and £  are at the same magnification (Bar=100 
Jim). Micrographs B, D  and F are  at the same magnification (Bar=50 pm).
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Figure 13. Histogram comparing PPT mRNA levels in OVX and estrogen treated groups 
after 90 days. Means for replacement groups are significantly lower than the OVX group 
(p <0.0001 for both comparisons).
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Effects o f Estrogen Treatments on Warm Thermal Withdrawal Latencies
Results o f the thermal withdrawal test indicate a trend o f reduced thermal 
sensitivity when estrogen replaced groups were compared to the OVX animals. Results 
o f the analyses o f warm thermal withdrawal latencies as measured with the warm plantar 
withdrawal testing apparatus are presented in Figure 14. These data were analyzed by a 
three (group) by seven (day) repeated measures analysis o f variance (ANOVA). The 
mean withdrawal latency for the OVX estrogen treatment group was less (meaning a 
shorter time for foot withdrawal) than that for the IX  estrogen treatment group which 
was, in turn, less than the mean withdrawal latency for the 10X group. On a daily basis, 
this phenomenon, though small, is surprisingly consistent. It is true for 18 out of 21 
means. However, the repeated measures ANOVA did not find significant differences for 
the main effect, that is a comparison of means for all subjects between groups. Each 
group terminated their trials significantly foster with repeated measurements, i.e., there 
was a day effect (p=.0014 ). The amount of this decline was not significantly different 
between groups.
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Figure 14. Comparison o f mean withdrawal latencies on seven successive days to a warm 
thermal stimulus.
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Effects o f Estrogen Treatments on 68kD Neurofilament mRNA Levels
Dramatic qualitative differences in hybridization o f the probe to these tissues are 
demonstrated. The 68kD neurofilament mRNA is most abundant in larger DRG neurons 
although all DRG neurons express the gene. Estrogen treatments dramatically increase 
the density of the silver grains over the larger neurons indicating increased steady state 
68kD neurofilament mRNA levels. The results o f in situ  hybridizations using an RNA 
probe to the 68kD neurofilament gene are shown in Figures 15-18. Figure 15 shows 
micrographs comparing the results of hybridization with the 68kD neurofilament 
antisense probe to DRG sections from the three groups after 56 days of estrogen 
treatment
Figures 16 and 17 show quantitative results o f these differences and reveal a 
possible dose-dependent effect of estrogen treatment on 68kD neurofilament gene 
expression. Similar to the data presented for trkA, experiments 1 and 2 use subjects 
from the same pool but are not identical. In the first experiment, the mean steady state 
68kD mRNA level for the OVX group was 540.10 g/rA  That for the IX estrogen 
treatment group was nearly four times greater (2069.85 g/rA), while that for the 10X 
estrogen treatment group was nearly six times greater (3279.35 g/rA). Statistical 
analyses revealed that these differences among groups were significant (p> .0001).
In the second in situ  hybridization experiment, the mean steady state 68kD 
neurofilament mRNA level for the OVX group was 1259.95 g/rA  the mean for the IX 
estrogen treatment group was nearly three time greater (3013.8 g/rA) while that 10X 
estrogen treatment group was nearly five times greater (5132.85 g/rA). Statistical
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analyses o f these data, as for the first experiment, differences among groups that are 
significant (p>.0001).
Figure 18 shows the results o f quantification o f mean steady state 68lcD 
neurofilament mRNA levels for the 90 day estrogen treatment regimen. These data vary 
slightly from the results o f the 56 day treatment regimen. Following 90 days o f estrogen 
treatments, the mean steady state 68kD neurofilament mRNA levels were nearly three 
times greater in the treatment groups (IX : 2952.35 g/rA  10X: 3426 g/rA) as compared 
to those o f the OVX group (1145.8 gr/rA). On the advice of Dr. Kolm, statistical 
analyses were not performed on these data since it was not possible to obtain grain 
counts from equal numbers o f DRG areas for the 10X group.
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Figure 15. Comparison o f results o f in  situ  hybridization o f DRG sections with anti- 
sense probe to neurofilament (68 kD) after 56 days o f estrogen replacement. 
Micrographs A, C and E  are shown in darkfield, and micrographs B, D  and F  are shown 
at a higher magnification with brightfield illumination. Sections shown in A  and B  are 
from OVX animal. Sections shown in C and D are from an animal receiving IX 
replacement estrogen. Sections shown in E  and F  are from an animal receiving 10X 
replacement estrogen. Bars in darkfield micrographs, A, C, and E  are 100 pm. Bars in 
brightfield micrographs B, D, and F a re  25 pm.
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□  Low Dose 
■  High Dose
Figure 16. Histogram comparing neurofilament mRNA levels in OVX and estrogen 
treated groups after 56 days, experiment 1. All means are statistically different from each 
other (p<  .0001).
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□  OVX 
□Low Dose 
■  High Dose
Figure 17. Histogram comparing neurofilament mRNA levels in OVX and estrogen 
treated groups after 56 days, experiment 2. Sections are from the same pool o f subjects 
as in experiment 1. All means are statistically different from each other (p  <.0001).











□  Low Dose 
■  High Dose
Figure 18. Histogram comparing neurofilament mRNA levels in OVX and estrogen 
treated groups after 90 days.
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DISCUSSION
The current study demonstrates that long-term estrogen replacement in OVX rats 
has profound effects on a number o f important DRG neuronal genes. Long-term 
estrogen replacement down-regulates the the high affinity NGF receptor, trkA gene, as 
well as, the PPT gene, which is responsible for the synthesis o f the putative nociceptive 
neuropeptide, substance P. In addition, long-term estrogen administration dramatically 
increases 68kD neurofilament mRNA levels. These findings are among the first to 
suggest direct effects o f long-term estrogen treatment on primary sensory neuronal gene 
expression. Such evidence provides initial insight into mechanisms that underlie altered 
somatosensory function during the reproductive cycle o f rats.
More importantly for the millions o f women facing loss o f estrogen, they suggest 
potential effects o f estrogen replacement therapy on skin sensation. The use o f estrogen 
replacement therapy for these women, to treat the obvious consequences o f estrogen 
loss, such as osteoporosis, is gaining greater acceptance. The implications o f the data 
from the current study for the increasing use of estrogen replacement therapy in 
menopausal women are obvious. The form, dosage, and time-course o f estrogen 
replacement may be critical and may depend on the specific symptoms and systems being 
treated. While chronic, long-term estrogen therapy might be beneficial in the treatment 
o f some systems, such as the skeletal or cardiovascular systems, the current data suggest 
that chronic, long-term estrogen treatment may alter somatosensory function and 
perhaps, in some instances, particularly nociception, have a deleterious effect.
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Estrogen Receptor Gene Expression in Lumbar DRGs
There has been a controversy in the literature regarding the number and types o f 
DRG neurons that express the ER gene. Sohrabji and her colleagues (1994) reported 
that ER mRNA was present in all DRG neurons. In contrast to these data, Sarajari and 
her colleagues (1996) reported that ER gene expression was characteristic o f a 
subpopulation o f predominantly smaller DRG neurons.
One goal of the current study was to resolve this controversy by determining 
whether all or only a subpopulation o f DRG neurons express the ER gene. The results 
of eight separate in situ hybridization experiments using probes to localize ER rmRNA 
within the lumbar DRG support those reports showing ER gene expression in only 
smaller DRG neurons (Sarajari and Oblinger, 1996). However, the final resolution of 
this issue may ultimately depend on methods with greater sensitivity for the detection of 
very low abundance mRNA in tissue sections.
To date, few photomicrographs o f ER mRNA have been published which use a 
radioactive label. It is difficult to compare results on the basis o f description alone. Only 
Simerly (1990) has published photomicrographs showing ER mRNA localization in the 
hypothalamus using this method. No one has published similar data for the spinal cord 
and DRG, both regions purported to have neuronal ER expression.
Cell biologists have suggested that ERs are largely recycled, that is, they return 
to the outer nuclear envelope after they detach from the estrogen response element of 
the gene (Ing and O’Malley, 1995). If  this is the case, the mRNA needed for the 
production of new receptors may be very low in abundance making it particularly 
difficult to detect by conventional in situ  hybridization methods.
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In the current study, our in situ  hybridization methodology revealed the results o f 
hybridization with radioactive probes to such high abundance mRNAs as 68kD 
neurofilament, PPT, and trkA within 1-2 weeks o f exposure o f the labelled slides to the 
NTB2 emulsion. By contrast, the m  situ  experiments yielding the best results for ER 
mRNA localization were exposed for 4-5 weeks or longer. Indeed, Oblinger (personal 
communication) used 16 week exposures to emulsion to reveal ER mRNA localization. 
Therefore, it remains a possibility that all DRG neurons may express the ER gene, but 
the technique available to us only allowed visualization of ER mRNA in some smaller 
neurons, where steady state ER mRNA levels are maximal. Quanitative analysis o f in 
situ hybridizations may be ineffective as a method of data analysis for low abundant 
mRNAs. The report showing ER mRNA localization in all DRG neurons used a 
digoxygenin labelling methodology (Sohrabji, et al., 1994). There is little reason, 
however, to believe that that particular approach is more sensitive than one using 
radioactively labelled RNA as a probe.
Differences in the fragment o f the ER gene selected for probe synthesis is another 
variable that may add to the disparity between studies. Sohrabji and her colleagues 
(1994) used a 48-base pair oligonucleotide probe constructed at their own university. 
All other in situ hybridization studies o f ER expression in nervous tissue use variations 
of the cDNA probe cloned by Miramatsu (Koike, et al., 1987). Because o f the very 
large degree of homology with other hormone receptors, it is critical to select the 
fragment for the probe from a portion o f the region coded for the receptor binding 
pocket. Both the Sohrabji group and the Sarajari group appear to accommodate this
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requirement. This region has very little homology with the binding pockets o f other 
hormone receptors.
In exploring the effects o f estrogen on nervous tissues, one must also consider 
potential non-genomic actions o f the hormone. The possibility that estrogen may enter 
DRG neurons by an as yet undescribed, additional route which bypasses the traditional 
ER is intriguing, fin general, non-genomic estrogen effects should be identifiable by 
their short latencies. These latencies are measured in minutes rather than hours and, as 
such, were beyond the resolution provided by the current study.
Regulation o f NGF Receptor Genes bv Estrogen
Clearly many questions remain concerning the relationship between estrogen and 
the neurotrophin, NGF. In order to begin to understand this relationship, one must begin 
by analyzing the effects of estrogen on the low-affinity (p75) and high-affinity (trkA) 
NGF receptors. The current study has established the effects of long-term estrogen 
treatment on trkA mRNA levels. Others have studied estrogen’s effects on the low- 
affinity NGF receptor, p75 (Gibbs and Pfaff 1992, Sohrabji et al, 1994 and Toran- 
Allerand et al, 1992).
Without first considering the effects o f estrogen, one finds that there remains 
some confusion about the interaction between p75 and trkA. The roles of these two 
receptors in mediating NGF’s action are not entirely understood. Emerging evidence 
indicates that p75, which may, more properly, be referred to as the neurotrophin 
receptor, influences the sensitivity o f DRG neurons to whichever of the tyrosine kinase 
type of receptors that they co-expressed, e.g. trkA, trkB or trkC (Wright and Snider,
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1995). Thereby, p75 may, in some way, determine the sensitivity o f a trkA expressing 
DRG neuron to NGF or a trkB expressing neuron to brain derived neurotrophic factor ( 
BDNF).
Because high affinity NGF binding and the intracellular effects of NGF on DRG 
neurons is dependent on trkA expression, the current study focused on the effects o f 
long-term estrogen treatment on trkA gene expression. In the current study, trkA 
mRNA levels were clearly and significantly downregulated by both IX and 10X daily 
estrogen treatments over 90 days. Treatments over the shorter, 56-day time period had 
similar effects.
These data show that chronic, long-term estrogen treatment decreases the 
amount o f trkA mRNA in lumbar DRG neurons. Such a decrease would be expected to 
decrease the production o f high-affinity NGF receptors by DRG neurons and thereby 
decrease the sensitivity o f these cells to the neurotrophin. This, in turn, should down- 
regulate NGF-dependent gene expression in the DRG. Further data from this study 
fulfill this expectation by showing a coincident effect o f estrogen treatments on DRG 
PPT gene expression.
Effects o f Estrogen Treatments on PPT Gene Expression and Nociception
As stated earlier, about 40% o f DRG neurons bind NGF and express the trkA 
gene. Of these, about half express the PPT gene. In those 20% o f DRG neurons, PPT 
gene expression (Hamar and Lindsay, 1989) and therefore, substance P levels (Wong and 
Oblinger, 1992) are regulated by NGF. Since, as discussed above, chronic, long-term
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estrogen treatment decreases DRG trkA. mRNA levels, it should have a downstream 
effect on NGF-regulated genes, such as the PPT gene.
The current data reveal a dose relationship between the effects o f chronic, long­
term estrogen treatment on trkA mRNA levels and the effects on PPT mRNA levels. 
Both 56 and 90 days o f daily estrogen treatment decreased PPT mRNA levels in both 
replacement groups compared to those o f the OVX groups. After 56 days the result is 
apparent.
Other than means, statistical analysis was not performed for the 56-day group for 
the following reason. This was because only a small tissue section was available for 
one animal (please see Methods) and only five data points were collected from one slide. 
Due to the restrictions o f the statistical test, i.e., an entirely balanced format, the 
decision was made to include data collected at the rate o f 10 data points per slide per 
animal for all other slides rather than discard half o f the data. (115 data points were 
collected rather than 120). However, no portion of this data is inconsistent with that for 
the 90-day group in which PPT mRNA levels in both replacement groups were 
decreased in comparison to that o f the OVX group. It is important to note that the 
replacement effect was not dose dependent since significant differences were not found 
between the two replacement groups.
Evidence from the current study support the results of an earlier, short-term 
study showing decreased substance P immunoreactivity in lumbar DRG neurons after 21 
days o f continuous estradiol replacement (Sarajari and Oblinger, 1995). Substance P is 
involved in the mediation of nociception and is characteristic o f small diameter axons 
from correspondingly small DRG neurons. A reduction in PPT gene expression and
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consequent decrease in substance P peptide levels should increase nociceptive 
thresholds, i.e. make the neurons less sensitive to painful stimuli. The results o f the 
testing, in the current study, using Hargreaves’ method of testing warm thermal 
withdrawal latencies generally uphold this expectation.
Warm Thermal Plantar Withdrawal Latencies
The OVX rats that received replacement estrogen showed a tendency to be less 
sensitive to noxious warm thermal stimuli as indicated by the time it took them to 
withdraw their hindlimb after onset of painful plantar stimulation. Although means for 
the 10X replacement group were higher than means for the IX group, which, in turn, 
were higher than the OVX group the differences between the means were not significant.
The lack o f statistically significant differences between treatment groups and the 
untreated OVX group may be due to inherent limitations in the apparatus and its 
measuring procedures. The phenomenon o f “spontaneous walk-offs”, which could occur 
within seconds of applying the stimulus are difficult to control for and as such, could not 
be separated from actual stimulus-induced withdrawals. Behavior such as paw licking or 
rapid jerks removing the foot from the heat source were often present as an indication of 
a response to noxious warm thermal stimuli. Conversely, a low-latency walk-off time 
with no apparent reaction to a noxious stimuli was suspicious as producing a false data 
point, yet lacked clear objective reason to be discarded as false. This variability 
accounted for a portion of the standard deviation. Since a learning effect was 
demonstrated, i.e. a quicker withdrawal response in all groups as the study progressed, 
retests for suspicious data points were also not appropriate.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
64
A second issue must also be considered in the interpretation o f these data. 
Although the Hargreaves’ device is referred to as a warm thermal testing apparatus, it is 
somewhat o f a misnomer. It more appropriately measures withdrawal from noxious 
warm stimuli. Kenshalo (1979) points out, in his review article, that psychophysical 
testing, i.e. detecting the presence o f a warm stimuli, discriminating temperature 
changes in warm stimuli and measuring withdrawal times from a noxious warm stimuli all 
have overlapping components but are distinctly different types o f discriminations. When 
appropriate, controls separating motivational components are used, tests in humans show 
that elderly females (compared to elderly males and younger males and females) have a 
reduced ability to sense pain from warm thermal stimuli (Clark and Mehl, 1971).
During the period o f peak estrogen levels, the proestrous phase o f the normal rat 
cycle, sensitivity to pain measured by thermal withdrawal (tailflick) was reported to be 
greatest (Frye, 1992). Although the results of the current study indicate a reduction in 
sensitivity to noxious warm stimuli with long-term continuously replaced estrogen, one 
must consider the potentially different impact of estrogen titers that rise and fall within 
days and an estrogen serum level that remains constant for a extended period. Indeed, in 
normally cycling animals, trkA mRNA levels are highest at proestrous, the time of peak 
circulating estrogen (Sohrabji, et al., 1994). From the current data, one would expea 
PPT mRNA levels to also be high at proestrous. If  so, substance P levels would be 
elevated in the DRGs and pain sensitivity should be heightened as shown by Frye (1992). 
For some as yet unknown reason, long-term, constant estrogen levels decrease trkA and 
PPT gene expression and thereby reduce sensitivity to noxious warm stimuli.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
65
The foot withdrawal tunes show a longer latency when each groups’ first day 
data is compared to its own seven-day mean. This apparently indicates a learning 
phenomenon, namely warmth paired with pain yields foot withdrawal to warmth 
discrimination. The role o f the hippocampus in learning and memory is widely accepted. 
The role o f estrogen on hippocampus is now being investigated in many 
laboratories(Klintsova, et al., 1995, Bettini, et al.,1992, Teyler, et al. 1980). Since the 
reduction in times within groups was not significantly different, no effects o f estrogen on 
learning are apparent in this study.
Effect o f Long-Term Estrogen Treatment on 68kD Neurofilament Gene Expression
Data from the current study show an estrogen-dependent increase in 68kD 
neurofilament mRNA levels. This response to estrogen appears to involve all or nearly 
all neurons. If only a subpopulation o f DRG neurons express the ER gene, the dramatic 
effects of estrogen on neurofilament gene expression in all or most DRG is more difficult 
to explain.
The 56-day group analyzed for neurofilament gene expression showed highly 
significant results while the data from the 90-day group was not as clear-cut. 
Replacement groups, Groups I and II and 1 of 2 subjects included in the OVX group 
produced data equivalent to the 56-day study.
The other subject in the OVX group was clearly different and produced results which 
were not significant. There are several possible explanations for this finding. It may be 
an indication o f a reversal o f the 56-day results such as the biphasic responses reported 
for estrogen’s effect on trkA mRNA levels in the forebrain (Gibbs, 1992). Another
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explanation may be that replacement estrogen responsiveness is innately variable. 
Authors in two studies (Sohrabji et al., 1994; Kow and Pfaf£ 1973) make specific points 
in their discussions concerning the unexpectedly large variability o f their measured 
dependent variables as o f result o f the administration o f exogenous estrogen. This
phenomenon was confirmed by a report at the recent, 1997 AFAR (American Federation 
of Aging Researech) meeting concerning replacement estrogen in humans (Kowas, 
personal communication). Either the very small subject number included in the OVX 90- 
day group could not show significant differences given a moderate amount o f 
intrasubject variability, not atypical to results of other estrogen replacement experiments, 
or, the dose-dependent upregulation o f neurofilament mRNA seen in the 56-day groups 
is not a feature of longer term treatment with the higher dose. In the case o f the 
acetycholinesterase-estrogen relationship in forebrain, the time-course o f a biphasic 
response is shortened as estrogen doses are increased (Luine, 1985).
Based on the population o f the DRG neurons in which neurofilament was 
upregulated, the current study found that estrogen working through its effect on NGF 
receptors could not account for the dramatic increase in mRNA levels demonstrated. 
Virtually all large neurons displayed a climactic increase in the amount o f neurofilament 
mRNA present following long-term estrogen treatment. Since exogenous NGF only 
restores neurofilament mRNA levels in NGF receptor-expressing neurons, predominantly 
smaller cells following axotomy (Verge, et al., 1990), estrogen must be working through 
a mechanism other than one associated with trkA gene expression.
Although it has been demonstrated that regulation o f neurofilament by NGF 
molecules results in a coordinate upregulation of all three neurofilament subunits genes
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in vitro (Lindebaum, 1988), neurofilament subunit gene expression may not always be 
coordinately upregulated in vivo, as suggested by the work of Muma and colleagues 
(1990).
Typically, however, in the adult DRG, neurofilament subunit gene expression is 
coordinate and therefore, long-term estrogen treatment would be predicted to upregulate 
the 1451cD and 200kD neurofilament genes. If so, one would predict further that 
treatment by estrogen would increase intermediate filament synthesis and assembly in 
DRG neurons. This would increase sensory axon diameters and consequently improve 
conduction velocities. This anticipated physiological correlate to estrogen treatment 
could easily be tested if the necessary testing equipment becomes available to the 
laboratory.
Use of Different Forms of Estrogen
Caution must be taken when comparing research studies that used different forms 
o f estrogen. Premarin (Wyeth-Ay erst), which was the form of estrogen used in the 
current study, is a commercial formulation widely used in clinical estrogen replacement 
therapy. It is from natural sources, namely pregnant mare urine (from which its name is 
taken). It is composed of a mixture of conjugated estrogens. According to Wyeth- 
Ayerst, the manufacturer, it has five components. The major components are estrone, 
equilin and 17 a-dihydroequilin. The minor components are 17 a-estradiol equilenin and 
17 a-dihydroequilenin. Washburn (1993) tested the components of Premarin. He 
examined ten forms o f estrogen present in Premarin individually. This suggests that the 
five components not listed by Wyeth-Ayerst are either in such minute quantities that
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reporting their presence in the formulation is not required or that the five additional 
components tested by Washburn are breakdown metabolites o f the five listed 
components.
According to Premarin’s manufacturer, Wyeth-Ayerst, estrogens are produced by 
the ovaries, which make several kinds o f estrogens. They further state that all estrogens 
have similar properties and therefore much the same usefulness, side effects and risks. 
While this is true at this time, it does not say that there are “no differences”, only that 
they have not been well investigated. Two studies (Washburn, et al., 1993 and 
Mermelstein, 1996) have looked specifically for and have found differences in the 
relative effects o f the various forms o f estrogen in different estrogen-responsive tissues.
Differential effects o f the individual Premarin components may allow benefits o f 
estrogen to be administered to women otherwise at risk for breast or endometrial 
cancer. During the normal aging process, the composition o f the circulating estrogen 
changes from predominantly estradiol to estrone (Erickson and Scheiber, 199S). This 
might suggest that the collateral benefits of estrogen to non-reproductive organs and 
tissues are maintained more by estrone than by estradiol.
Is estrogen a nervous tissue growth factor and does it interact with growth 
factors other than NGF? It is known that estrogen promotes the growth of some tumors 
in breast and endometrium and therefore, acts as a growth factor in these tissues. One 
study has indicated a possible connection with insulin-like growth factor (IGF) in the 
nervous system (Toran-Allerand et al, 1988). In that study, explants of hypothalamus 
and forebrain were used. The data from the study clearly suggested that estrogen may 
act synergistically with growth factors other than NGF, such as IGF. This may be true
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for the DRG where neurons are known to be responsive to  members o f the insulin gene 
family.
Resolution o f Apparently Conflicting Results
How can results (Sohrabji, et al, 1994) demonstrating an upregulation in trkA in 
the DRG after estrogen administration be reconciled with the results of the current 
study? The time course and dosage are apparently critical. Demonstration of a biphasic 
response to estrogen in the CNS first emerged with the the interaction of estrogen and 
choline acetyl transferase (ChAT) in basal forebrain. Not only was the measured effect 
reversed after long-term exposure, but the time course o f this reversal was dose 
dependent (Liune, 1985).
The emerging story on the low affinity NGF receptor has given us additional 
clues. Recent data examining the effect o f extended administration o f estrogen on p75 in 
basal forebrain neurons parallels the findings in the current study. This study (Gibbs and 
Pfaff, 1992) found that after two weeks o f estrogen replacement in rat the activity of 
p75 was reversed compared to that found at earlier times .
A consistent story is emerging which seems to reconcile the apparently 
contradictory results o f previous and current studies. Firstly, trkA and p75 act 
inversely at each group o f time points (short term vs. long term) and conversely from 
short term to long term. Our report examined only trkA, but the combined data of 
several labs now makes sense.
Short-term exogenous estrogen replacement (approximating the timing of the 
normal rat estrus cycle) as well as endogenous high levels o f estrogen (proestrous levels)
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in normally cycling rats result in an upregulation o f trkA and a downregulation o f p75 in 
the basal forebrain and lumbar DRGs (Gibbs, 1992, Toran-Allerand, 1992 and Sohrabji,
1994). In contrast, long term, continuous estrogen replacement results in a down­
regulation o f trkA (Gibbs and Pfaf£ 1992) in forebrain and in DRG (current study) and 
an upregulation o f p75 in forebrain (Gibbs, 1992).
An analysis o f known data concerning substance P, PPT and the resultant 
response o f withdrawal to noxious warm stimuli follows logically. Over the short term 
an upregulation o f trkA during proestrous would expectedly yield an upregulation of 
substance P resulting in greater sensitivity to noxious warm stimuli (Frye, 1988) during 
normal cycling. Conversely, over the long-term a down-regulation of trkA would be 
expected to yield a down-regulation of substance P in DRG (Sarajari and Oblinger,
1995) and PPT in DRG (current study) as well as diminished sensitivity to noxious 
warm stimuli (current study).
The results show that the DRG cell populations containing ER, trkA and PPT 
mRNAs are overlapping. Many small DRG neurons contain ER, PPT (substance P) and 
trkA In the current study neither the regulation o f PPT nor the regulation o f trkA 
mRNA levels by estrogen was dose-dependent.
The cell population and the dynamics involving NGF and neurofilament 
(Hoffinan, 1984, 1985, and 1987) and estrogen, NGF (receptor) and neurofilament in 
this study are very different from the cell population and dynamics involved with NGF 
(receptor) estrogen and PPT. Neurofilament mRNA levels after long-term (56-day) 
estrogen replacement are increased and are dose dependent. Whether the time course is 
merely different from that seen for PPT and trkA, and that an eventual down-regulation
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for neurofilament occurs with continuous replacement is uncertain. Although the mean 
mRNA level for the 90-day 10X is much higher than that for either the IX  or the OVX 
group, the mean disguises the fact that the animals within this group reflect very 
different means (variability) and hence the 10X group is not statistically different from 
the IX group. Whether this reflects a deterioration o f the phenomenon observed at 56 
days or not cannot be determined at this point.
Alterations in sensory function resulting from changes in estrogen levels are 
largely unexplored. A few scattered papers indicate intriguing possibilities in several 
sensory modalities. Hearing might be affected by estrogen. ERs have been found 
recently in the cochlear nucleus (Simeriy, 1990) and estrogen levels have been reported 
to affect . In the auditory system, one study (Coleman, et al., 1994) has reported 
differences based on estrogen status. The results o f this study provide a significant and 
positive result which has many ramifications and opens the possibilities for broadened 
investigations on the effects o f estrogen on sensation. Finally, the hypothesis can be 
raised, does estrogen affect sensation in males, and how do other hormones affect 
sensation? It is entirely unknown whether males have estrogen receptors on sensory 
cells. Whether or not parallel processes occur in males with different hormones is also 
unknown. What is known is that males convert testosterone to estrogen with the 
enzyme aromatase in certain basal forebrain nuclei, i.e. a mechanism exists in the nervous 
system of males which makes testosterone conversion to estrogen a possibility. Also, 
males show an increase in cutaneous receptive field after the administration o f exogenous 
estrogen (Kow and PfafF, 1973). Considering the highly homologous nature o f all
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steroid hormones and their receptors, it is not unlikely that some non-specific binding 
may occur between hormones and their ligands.
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CONCLUSIONS 
Traditionally, the effects o f estrogen in brain have been characterized as effects 
associated with reproduction. The role o f the hypothalamus as a regulator o f the 
reproductive cycle is well documented. Yet, perhaps it is our definition o f reproductive 
behavior which needs to be re-examined. In the animal studies in which an increase in 
skin sensitivity was shown to occur as a result o f estrogen, behavior indicating the 
female’s acceptance o f the male can be identified as the probable link to reproduction. 
Nesting behavior, a secondary reproductive function was documented in the canary 
brood patch study. In the current Physicians Desk Reference’s review on Premarin, it 
states that one o f the effects o f this hormone replacement is a dramatic increase in the 
number of reports o f sexual fantasy. The possible number o f synapses which are 
involved in this neural activity are imponderable, yet somehow occur as a result of 
estrogen replacement. When we consider that the role o f sex is, o f course, directly 
responsible for the survival o f the species, it makes sense that the molecule o f estrogen is 
probably as old as sexual reproduction itself and that its role within each species has 
evolved as well. What we define as sexual behavior may be broadened to include many 
behaviors secondary to the reproductive cycle, per se.
During the normal process of aging the primary reproductive function for 
females ceases. The point is, o f course, that the role o f estrogen in the normal aging 
body has many overlapping functions with that o f secondary sexual and reproductive 
behavior. For example, skin sensitivity, which is important in mating and nesting 
behavior, is important during all ages of one’s life.
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The somatosensory sensations include vibration sense, two-point touch 
discrimination, pain and temperature as well as proprioception. These sensations make 
use o f different subsets o f receptors and are subserved by different groups o f DRG 
neurons. The experiments in this paper have begun to sort out how long-term 
continuous estrogen replacement affects these DRG neurons and the sensations which 
they carry.
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Protocol for Riboprobc Synthesis
Dry down even aliquots o f 33P in speed-vac fo r30 minutes.
Set up 10 ul transcription rxns (n + 1 ): X I  X.
2 ul transcription buffer






Add 7 ul transcription rxn to dried down isotope and vortex.
Add 2 ul o f {2ug/ul} D N A  template (sense and antisense o f each).
Add I ul of appropriate polymerase enzyme to appropriate tube:
DCfA. Polymerase Enzvme
A
Incubate tubes for 1 hou r at 37*C .
Tough rxn mixture w ith m icrqtip and rinse in 5 ul o f DEPC H 20. Spot 2  ul on chromotography strip and 
allow to air dry. Place spotted end in IM  KH2P04 and allow buffer to run to top o f strip.
A ir dry strip and expose to film  for 30 minutes.
Stop transcription rxn by adding I ul Dnase to each tube and incubate for 15 min at 37* C.
Add 30 ul DEPC H 2 0  to bring to final volume o f 40 ul per tube.
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Protocol for in situ Hybridization
Deparaffinate: Xylene 5 min 3X
100 % ETO H 3 min 2X
95%  ETOH 3 min 1X
70%  ETOH 3 min IX
50%  ETOH 3 min 1X
PRE-HYBRIDIZATION
1. Incubate sections in 0.02M  H C L 10 m in  a t RT. (Partially solubilizes th e highly cross-linked acidic 
nuclear proteins, enabling easier access to the probe.)
(300 ul H C L in 200  m is DEPC H 2 0 )
2. W ash in 1X PBS 5 m in , 2 X
(20 ml 10X  PBS in 180  m l DEPC H 2 0 )
3. W ash in  1 X  PBS th a tis  0.01%  Triton X -1 0 0  90 sec.
(20 ul in 20 0  m l 1X  PBS)
4. Rinse b rie fly  in DEPC  H 2 0 .
5. Treat w ith 2 X S S C  a t 7 0 *C  30 m in . (Loosens lipid membrane proteins.)
(20 ml 20 X  S S C  in 180 m l DEPC H 2 0 )
6. Proteinase K  trea t a t 37 *C  30 m in . (D egrades many of ttie cross-linked 
proteins.)
(20 m l 1M  Tris, 2 0  ml 0 .5M  E D TA in 160  m l DEPC H 2 0 . Add 100-200 ul o f 10  m g/m l Proteinase K 
just prior to  adding slides.^ -
7 . Rinse b rie fly  in  D E P C  H 2 0 .
8. fix  in 4%  form aldehyde or paraform aldehyde, 1X  PBS 10 m in. (H elps to prevent loss of r ‘ "-ieic 
add sequences during remaining steps.)
(180 m l 4%  form aldehyde plus 20 ml IX  PBS)
9. Rinse b rie fly  in 1X  PBS.
10. Acetyl ate 10 m in while shaking 0.1M  T E A  with acetic anhydride added just before slides.
(Reduces level o f endogenous alkaline phosphatase in the tissue.)
(20 ml 1M TE A  in 180 ml DEPC H 2 0  plus 500 ul acetic anhydride ad d e d  just prior to adding 
slides.)
11. Rinse in 2 X  SSC  1 m in.
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